Patients from 22+ countriesPlan your visit โ†’
lutetium-therapy
World-Class Lutetium Therapy ยท India

The world's most advanced cancer therapy, delivered with the world's warmest care.

Lutetium-177 is precision radiation that finds cancer cells one at a time. Patients from 22+ countries travel to our center in India for advanced Lu-177 therapy - proven outcomes, international protocols, and transparent fixed pricing at $6,000โ€“$8,000 USD per session.

Medically reviewedUpdated 14 Nov 2024ยท Powered by Art of Healing Cancer
How it works
Lu-177 attaches to a molecule that finds the cancer cell's receptor - like a key in a lock.
The Science, Gently

This isn't the radiation you're thinking of.

External-beam radiation aims a machine at your body. Lutetium therapy works completely differently.

A single amber-colored targeting molecule precisely aligning toward one specific docking point on a translucent cell

It finds cancer cells

Lu-177 is attached to a molecule that recognizes a specific marker on the surface of your cancer cells - like a key fitting only one lock.

A single cell glowing warmly from within at one spot - the glow contained tightly, surrounding cells unaffected

It delivers radiation precisely

Once bound, Lu-177 releases radiation that travels just 2 millimeters - destroying the cancer cell while sparing the healthy tissue right next to it.

Amber Lutetium molecules flowing through a blood vessel past red blood cells, heading toward target cancer cells visible in the distance

It travels through your bloodstream

It's given as a 30-minute IV infusion. You walk in, sit in a chair, and walk out. Most patients return home the same day.

What's Possible

Real outcomes. Real time. Real quality of life.

For many patients, Lutetium therapy delivers the most meaningful results they've seen in years - extending life, restoring energy, and offering months to years of stable disease, often with far better quality of life than chemotherapy.

In the VISION trial, Lu-177 PSMA therapy significantly extended overall survival in advanced prostate cancer. Many patients saw their PSA drop dramatically. Pain eased. Energy returned. Activities they thought they'd lost came back into reach.

In the NETTER-1 trial, Lu-177 DOTATATE therapy held neuroendocrine tumors stable for a median of 28 months - more than three times longer than the standard alternative. For patients who respond, that often translates into years of normal life with disease firmly under control.

Every patient's response is their own. Our experienced team is here to help you understand what these results could mean for you - and to walk with you every step of the way.

Aerial view of an Indian city at golden hour - the destination patients travel to from 22+ countries for advanced Lutetium therapy
22+
countries our patients call home before traveling to India
Why Patients Choose Us

One of the world's most experienced Lutetium therapy centers - in India.

We've dedicated our practice to Lu-177 therapy. International protocols. In-house radiopharmaceutical preparation. A multidisciplinary team that has guided patients from 22+ countries through complete treatment courses. Transparent fixed pricing at $6,000โ€“$8,000 USD per session.

Patients from 22+ countries

US, UK, Middle East, Africa, SE Asia, Australia, New Zealand, and across India.

World-class protocols

Same evidence, same molecules, same procedures used at leading global centers.

In-house radiopharmacy hot lab

Fresh Lu-177 PSMA-617 and Lu-177 DOTATATE prepared on-site, every visit.

Dedicated international team

Visa support, accommodation, language assistance, end-to-end coordination.

Researching for someone you love?

Most of our readers are not the patient - they're the spouse, child, or friend doing the homework. We built this site for you too.

The caregiver's guide

Why you can trust what you read here.

Medically Reviewed

Every clinical page is reviewed by an oncologist or nuclear-medicine physician with named credentials.

Always Sourced

Every statistic links to its peer-reviewed source. We never make claims we can't substantiate.

Kept Current

Pages are reviewed at least every 12 months. The last-reviewed date is visible on every clinical page.

Stay informed without being overwhelmed.

One email a month. New trial results, plain-language updates, and patient stories. No spam, ever. Unsubscribe in one click.

We never share your email. We never sell data. Read our privacy policy.

Have a specific question? Talk to a navigator.

Free conversation with a trained patient navigator. They'll help you understand your options, prepare questions for your oncologist, and explore treatment centers.

Navigators don't diagnose or prescribe. They help you have better conversations with the doctors who do.